Treatment to target in Type 2 diabetes: successful glycaemic control with less nocturnal hypoglycaemia with insulin glargine versus NPH insulin added to oral therapy

被引：0

作者：

Riddle, M

Rosenstock, J

机构：

[1] Oregon Hlth Sci Univ, Dept Med, Portland, OR 97201 USA

[2] Dallas Diabet & Endocrine Ctr, Dallas, TX USA

来源：

DIABETOLOGIA | 2002年 / 45卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

150

引用

页码：A52 / A52

页数：1

共 50 条

[1] Treatment to target study: Insulin glargine vs NPH insulin added to oral therapy of type 2 diabetes. Successful control with less nocturnal hypoglycemia
Riddle, MC
Rosenstock, J
DIABETES, 2002, 51 : A113 - A113
[2] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
Fritsche, A
Schweitzer, MA
Häring, H
DIABETOLOGIA, 2002, 45 : A52 - A52
[3] Glycaemic control and hypoglycaemia in Asian Type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
Pan, CY
Bianchi-Biscay, M
Chung, KD
Kim, KW
DIABETOLOGIA, 2004, 47 : A271 - A271
[4] Insulin glargine is associated with less hypoglycaemia than NPH insulin in older patients with Type 2 diabetes
Riddle, M
Massi-Benedetti, M
Häring, HU
Dailey, G
Murray, F
Lin, Z
Rosenstock, J
DIABETOLOGIA, 2004, 47 : A328 - A328
[5] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, Chang-Yu
Sinnassamy, Patrick
Chung, Kab-Do
Kim, Kwang-Won
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
[6] Insulin glargine vs. NPH insulin in patients with Type 1 diabetes: the effects of intensive insulin therapy on glycaemic control, hypoglycaemia and quality of life.
Fulcher, G
Yue, D
Gilbert, R
DIABETOLOGIA, 2002, 45 : A258 - A258
[7] 2-year glycaemic control after initiation of insulin glargine or NPH insulin in type 2 diabetes
Leahy, J. L.
Dain, M. -P.
Rhoads, G. G.
Kennedy, L.
DIABETOLOGIA, 2008, 51 : S405 - S405
[8] Co-administration of insulin glargine with oral therapy in patients with Type 2 diabetes allows flexible dosing and improved glycaemic control with reduced hypoglycaemia compared with NPH insulin.
Busch, K
Fritsche, A
Häring, HU
Schweitzer, MA
Vesper, I
DIABETOLOGIA, 2003, 46 : A6 - A6
[9] Economic impact of nocturnal hypoglycemia associated with the treatment of type 2 diabetes with insulin glargine or NPH insulin
Rubio-Terres, Carlos
Alvarez Guisasola, Fernando
Navarro Perez, Jorge
Delgado Alvarez, Elias
Azriel Mira, Sharona
Magana, Ana
AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 19 - 26
[10] EFFECTS OF METFORMIN AND SULFONYLUREA ON EFFICACY AND HYPOGLYCAEMIA WHEN ADDED TO GLARGINE OR NPH INSULIN IN TYPE 2 DIABETES
Bretzel, R. G.
Traylor, L.
Landgraf, W.
DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A90 - A90

← 1 2 3 4 5 →